Effective Treatment of Prurigo Nodularis With Oral Tofacitinib: A Case Report
Recent advancements in understanding the potential pathogenesis of prurigo nodularis (PN) have paved the way for the development of new, targeted therapies. Emerging evidence suggests that JAK inhibitors may provide a safe and effective treatment option for both atopic and non-atopic PN. Here, we present a case of refractory PN successfully treated with tofacitinib.
Authors
- Nikoo Mozafari (ORCID: https://orcid.org/0000-0003-4691-2606)
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/ccr3.70287
- Citations
- 3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.01